Ask an Advisor: Should I Keep Reinvesting My Dividends or Start Taking the Cash?
Is there a point at which I should stop reinvesting stock dividends and invest the money or save the cash?
-Anonymous
Many financial experts recommend that you reinvest dividends most of the time – and I’m inclined to agree. The process is typically automated, doesn’t incur any fees and gives your holdings a little (or a lot) of extra oomph.
For example, if you had invested in Microsoft stock 10 years ago and consistently reinvested your dividends since then, your holdings would be worth 63% more today than if you hadn’t reinvested. That’s a lot of oomph.
Still, there is hardly ever a one-size-fits-all answer to any investment question. Accordingly, it may be wiser in some situations to just take the money rather than reinvest it.
Here’s what investors should know about when it makes sense not to reinvest dividends.
A financial advisor can help you finetune your investment strategy. Find a fiduciary advisor today.
3 Good Reasons to Not Reinvest Dividends
While reinvesting dividends will almost always give your stock holdings a shot in the arm, sometimes your big-picture needs as an investor will trump those potential benefits.
Here are three common examples of situations in which it makes sense to not reinvest dividends:
-
Balancing your portfolio. Reinvesting dividends will increase your position in the company paying them. If that company already represents, say, 5% or more of your portfolio, it may be wise to avoid getting too concentrated and not reinvest your dividends.
-
Phasing out risk. In many cases, it’s a good idea to make your investments less aggressive over the years. If you’ve been reinvesting dividends, diverting that cash toward less aggressive assets (like bonds) can be a good way to “risk-off” smoothly.
-
Income. Remember: Money is ultimately for spending, and sometimes you just need the cash. There’s nothing wrong with that, especially if you’re in or approaching retirement when short-term income becomes a bigger priority than long-term growth.
1 Bad Reason to Not Reinvest Dividends
Some people will say that you shouldn’t reinvest dividends if the underlying stock isn’t performing well. Here, however, I completely disagree.
Remember, one of the main benefits of dividends is that they pay out regardless of the stock’s recent price movement. This indicates that the company paying them has an established track record of earning profits – a clear sign that the company is fundamentally worth investing in.
In other words, even if the share price is in a slump, odds are it will recover eventually. So if you’re going to hold onto the stock anyway, and therefore keep receiving dividends, why not keep getting the extra boost from reinvesting them?
As I like to remind my clients, we invest in companies, not stocks. The share price is only one indication of a company’s value, and sometimes a very unreliable one. That truth is often forgotten and always important. Consider consulting a financial advisor for more personalized advice on your portfolio.
What to Do Next
If you’re receiving dividends and are unsure of what to do with them, remember the fundamentals.
Deciding what to do with your dividends boils down to answering three questions:
-
Am I confident in the company’s underlying health?
-
Can I afford to reinvest the dividend income right now?
-
Is increasing my position in this company consistent with my overall portfolio strategy?
If the answer to any of these questions is “no” or “I’m not sure” then you may want to spend that dividend cash elsewhere.
If you can answer all of them with “yes,” however, then let the reinvestment machine keep doing its thing.
Investing and Retirement Planning Tips
-
If you have questions specific to your investing and retirement situation, a financial advisor can help. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
-
For more about dividend investing check out this article on the subject.
-
As you plan for income in retirement, keep an eye on Social Security. Use SmartAsset’s Social Security calculator to get an idea of what your benefits could look like in retirement.
-
Keep an emergency fund on hand in case you run into unexpected expenses. An emergency fund should be liquid — in an account that isn’t at risk of significant fluctuation like the stock market. The tradeoff is that the value of liquid cash can be eroded by inflation. But a high-interest account allows you to earn compound interest. Compare savings accounts from these banks.
-
Are you a financial advisor looking to grow your business? SmartAsset AMP helps advisors connect with leads and offers marketing automation solutions so you can spend more time making conversions. Learn more about SmartAsset AMP.
Graham Miller, CFP® is a SmartAsset financial planning columnist and answers reader questions on personal finance topics. Got a question you’d like answered? Email AskAnAdvisor@smartasset.com and your question may be answered in a future column.
Please note that Graham is not a participant in the SmartAsset AMP platform, nor is he an employee of SmartAsset. He was compensated for this article.
Photo credit: ©iStock.com/visualspace, ©iStock.com/gorodenkoff
The post Ask an Advisor: Should I Stop Reinvesting Dividends? appeared first on SmartAsset Blog.
Bio-coatings Market to Reach $17.4 Billion, Globally, by 2033 at 6.9% CAGR: Allied Market Research
The global bio-coating in the construction market is experiencing growth due to several factors such, Sept. 06, 2024 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Bio-coatings Market by Resin (Alkyd, Polyurethane, Acrylic, and Others) , and Application (Transportation, Construction, Woodworking, Packaging, and Other) : Global Opportunity Analysis and Industry Forecast, 2024-2033″. The global bio-coatings market was valued at $9.3 billion in 2023 and is estimated to reach $17.4 billion by 2033, exhibiting a CAGR of 6.9% from 2024 to 2033.
Prime determinants of growth
The global bio-coatings market is experiencing growth due to several factors such as a growing awareness of environmental issues and the need for sustainable solutions is a primary driving force behind the adoption of bio coatings. Furthermore, the rise in consumer awareness and preferences for eco-friendly products drive demand for bio coatings. However, the high cost of bio coatings hinders market growth to some extent. Moreover, industries such as construction, automotive, packaging, and consumer goods are increasingly adopting bio coatings to align with sustainability goals and meet consumer expectations offers remunerative opportunities for the expansion of the global bio-coatings market.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A323751
Report coverage & details:
Report Coverage | Details |
Forecast Period | 2024–2033 |
Base Year | 2023 |
Market Size in 2023 | $9.3 billion |
Market Size in 2033 | $17.4 billion |
CAGR | 6.9% |
No. of Pages in Report | 288 |
Segments Covered | Resin, Application and Region |
Drivers | Technological advancements in the bio-coatings industry Increase in promotion of sustainability coating products Surge in construction activities in Asia-Pacific Surge in government incentives for environmental issues |
Opportunities | Rapid industrialization and urbanization Surge in changing consumer preferences towards eco-friendly and sustainable products |
Restraint | High-cost consideration |
The alkyd segment is expected to exhibit fastest growth throughout the forecast period.
Based on resin, the alkyd segment held the highest market share in 2023 and is likely to retain its dominance throughout the forecast period. Bio-based alkyd coatings, derived from renewable resources such as plant oils or bio-based resins, offer a more environmentally friendly option compared to petroleum-based alkyd coatings. Alkyd could be up to 100% bio-based and performing efficiently. The basic components used in the production of an alkyd are fatty acids, di-acids and polyol. The demand for alkyd in bio coatings is driven by packaging and construction industry. As construction activities expand globally, the need for bio-based alkyd rises to meet the escalating demands of the sector.
Procure Complete Report (288 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/bio-coatings-market
The construction segment is expected to exhibit fastest growth throughout the forecast period.
Based on application, the construction segment held the highest market share in 2023 and is likely to retain its dominance throughout the forecast period. Bio coatings offer durability, weather resistance, and other functional properties which meet the performance requirements of building materials. Advances in bio coating technologies have improved their performance characteristics, making them suitable for a wide range of applications in the construction and architectural industry. Moreover, the rising desire for bio coatings is propelled by urbanization, population expansion, and the necessity for infrastructure. As construction endeavors within the country escalate, it is expected to increase the demand for bio coatings in the construction sector.
Asia-Pacific to maintain its dominance by 2032.
Based on region, Asia-Pacific held the highest market share in terms of revenue in 2023 and is expected to rule the roost in terms of revenue throughout the forecast timeframe. The rapid industrialization in countries such as China and India have led to the establishment and expansion of manufacturing facilities, including automotive, construction, and packaging. These industries rely heavily on paint and coating products to maintain the quality of the product.
Players: –
- The Sherwin-Williams Company
- Axalta Coating Systems Ltd.
The report provides a detailed analysis of these key players in the global bio-coatings market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Want to Access the Statistical Data and Graphs, Key Players’ Strategies: https://www.alliedmarketresearch.com/bio-coatings-market/purchase-options
Recent industry development:
- On March 9, 2023, PPC industries decided to launch SIGMAGLIDE 2390 marine coating product. The coating is expected to help ship owners lower power consumption and carbon emissions, meeting the demand for higher performance with no adverse impact on the marine environment.
- On December 8, 2022, BASF company launches automotive coatings named “ColorBrite” using renewable raw materials according to a certified biomass balance approach. This development helps the company to increase the product portfolio and revenue in the near future.
- On November 21, 2022, Arkema announced a major step forward in its innovative sustainable offer with the certification of a range of bio-attributed acrylic monomer. The development of these bio-attributed acrylic materials is an important step on the sustainable development roadmap of Arkema and its Coating Solutions segment.
- On April 1, 2022, PPG industry announced that the company has completed the acquisition of the powder coatings manufacturing business of Arsonsisi, an industrial coatings company based in Milan, Italy. This development helped the company to increase the customer base and revenue.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
Blog: https://www.newsguards.com/
Follow Us on | Facebook | LinkedIn | YouTube |
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Positive Signal: David Michael Braner Shows Faith, Buying $299K In American Public Education Stock
A notable insider purchase on September 4, was reported by David Michael Braner, Director at American Public Education APEI, based on the most recent SEC filing.
What Happened: In a recent Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, Braner increased their investment in American Public Education by purchasing 17,872 shares through open-market transactions, signaling confidence in the company’s potential. The total transaction value is $299,713.
American Public Education shares are trading up 1.58% at $15.73 at the time of this writing on Thursday morning.
All You Need to Know About American Public Education
American Public Education Inc provides online and on-campus postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.
Unraveling the Financial Story of American Public Education
Revenue Growth: Over the 3 months period, American Public Education showcased positive performance, achieving a revenue growth rate of 3.86% as of 30 June, 2024. This reflects a substantial increase in the company’s top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Analyzing Profitability Metrics:
-
Gross Margin: Achieving a high gross margin of 50.15%, the company performs well in terms of cost management and profitability within its sector.
-
Earnings per Share (EPS): American Public Education’s EPS is below the industry average. The company faced challenges with a current EPS of -0.07. This suggests a potential decline in earnings.
Debt Management: American Public Education’s debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.82, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Insights into Valuation Metrics:
-
Price to Earnings (P/E) Ratio: American Public Education’s stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 81.53.
-
Price to Sales (P/S) Ratio: The P/S ratio of 0.45 is lower than the industry average, implying a discounted valuation for American Public Education’s stock in relation to sales performance.
-
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): American Public Education’s EV/EBITDA ratio at 7.46 suggests potential undervaluation, falling below industry averages.
Market Capitalization Analysis: Positioned below industry benchmarks, the company’s market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Impact of Insider Transactions on Investments
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
In the context of legal matters, the term “insider” refers to any officer, director, or beneficial owner holding more than ten percent of a company’s equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider’s new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
A Closer Look at Important Transaction Codes
When dissecting transactions, the focal point for investors is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of American Public Education’s Insider Trades.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Super Micro Computer Stock Fell Today and Is Now Down 67.5% From Its High — Time to Buy Before Its Stock Split?
Super Micro Computer (NASDAQ: SMCI) stock was battered again in Friday’s trading. The server company’s share price ended the session down 6.8%, according to data from S&P Global Market Intelligence.
Supermicro’s latest slide followed news that JPMorgan‘s analysts had lowered their rating on the stock from overweight to neutral and cut their price target on it from $950 per share to $500 per share. Additionally, the Labor Department’s jobs report Friday showed that only 142,000 jobs were added to the U.S. economy in August, falling short of Wall Street’s expectation that 160,000 jobs would be added.
Supermicro’s share price is now down 67.5% from the high it reached earlier this year. Should investors consider buying the stock in the lead-up to the company’s stock split on Oct. 1?
Supermicro stock is a buy for risk-tolerant investors
Super Micro Computer has been hit with a series of bearish news events recently. The company’s fiscal fourth-quarter report arrived in early August with margins that spooked the market and pointed to some rising competitive pressures. Then in late August, Hindenburg Research published a scathing short report on the stock. Supermicro also announced that it was delaying the filing of its 10-K report for its fiscal 2024, which ended June 30.
Now, JPMorgan has downgraded the stock and dramatically reduced its price target.
The bearish indicators seem to be piling up, but I think the significance of some of them is being overblown. For starters, investors should keep in mind that Hindenburg Research is a short-seller that profits when a stock it has bet against goes down. Additionally, Supermicro has reiterated that it does not expect to make any material changes to the results it has already reported for fiscal 2024.
And Friday’s note from JPMorgan? While the company lowered its price target, its new 12-month forecast for a $500 per share price still suggests upside of roughly 29% compared to Friday’s closing price.
Supermicro isn’t a low-risk stock, but the shares, trading at roughly 11 times this year’s expected earnings, look cheaply valued. For investors with a higher tolerance for risk and volatility, buying the stock at these levels could have a big payoff down the road.
Should you invest $1,000 in Super Micro Computer right now?
Before you buy stock in Super Micro Computer, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Super Micro Computer wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $656,938!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
*Stock Advisor returns as of September 3, 2024
JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends JPMorgan Chase. The Motley Fool has a disclosure policy.
Super Micro Computer Stock Fell Today and Is Now Down 67.5% From Its High — Time to Buy Before Its Stock Split? was originally published by The Motley Fool
Purpose Announces Corrections to Risk Ratings for Certain Funds
TORONTO, Sept. 06, 2024 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) today announced changes to the risk ratings for 16 public investment funds under its management (collectively, the “Funds”). These changed risk ratings have been determined in accordance with the standardized risk classification methodology mandated by the Canadian Securities Administrators. In the course of internal reviews, Purpose noted that the Funds have been inadvertently reporting incorrect risk ratings. Effective immediately, the new risk ratings of the Funds are set out in the table below.
The following Funds have a risk rating increase:
Fund Name | Ticker Symbol | Current Risk Rating | New Risk Rating |
Purpose Global Bond Class | TSX: IGB | Low | Low to Medium |
Purpose Enhanced Premium Yield Fund | TSX: PAYF | Low to Medium | Medium |
Purpose Best Ideas Fund | TSX: PBI, PBI.B | Medium | Medium to High |
Purpose Core Dividend Fund | TSX: PDF | Low to Medium | Medium |
StoneCastle Equity Growth Fund | – | Medium to High | High |
StoneCastle Income Growth Fund | – | Low to Medium | Medium |
Purpose Core Equity Income Fund | CBOE: RDE | Low to Medium | Medium |
Purpose Enhanced Dividend Fund | TSX: PDIV | Low to Medium | Medium |
Purpose International Dividend Fund | TSX: PID | Low to Medium | Medium |
Purpose Emerging Markets Dividend Fund | CBOE: REM | Low to Medium | Medium |
Amazon (AMZN) Yield Shares Purpose ETF | CBOE: YAMZ | Medium | Medium to High |
Tesla (TSLA) Yield Shares Purpose ETF | CBOE: YTSL | Medium to High | High |
Alphabet (GOOGL) Yield Shares Purpose ETF | CBOE: YGOG | Medium | Medium to High |
Apple (AAPL) Yield Shares Purpose ETF | CBOE: APLY | Medium | Medium to High |
The following Funds have a risk rating decrease:
Fund Name | Ticker Symbol | Current Risk Rating | New Risk Rating |
Longevity Pension Fund | – | Low to Medium | Low |
Purpose Gold Bullion Fund | TSX: KILO, KILO.B, KILO.U | Medium to High | Medium |
There is no change to the investment objectives, strategies, or management of the Funds associated with the new risk ratings. The above changes will be reflected in the Funds’ prospectuses (where applicable), fund facts documents, and/or ETF facts documents, which will be available on the SEDAR+ website (www.sedarplus.ca).
Purpose has reviewed and updated its internal communication protocols to ensure all practices are sound.
About Purpose Investments Inc.
Purpose Investments is an asset management company with approximately $20 billion in assets under management. Purpose Investments has an unrelenting focus on client-centric innovation and offers a range of managed and quantitative investment products. Purpose Investments is led by well-known entrepreneur Som Seif and is a division of Purpose Unlimited, an independent technology-driven financial services company.
For further information please contact:
Keera Hart
Keera.Hart@kaiserpartners.com
905-580-1257
Commissions, trailing commissions, management fees and expenses all may be associated with investment fund investments. Please read the prospectus and other disclosure documents before investing. Investment funds are not covered by the Canada Deposit Insurance Corporation or any other government deposit insurer. There can be no assurance that the full amount of your investment in a fund will be returned to you. If the securities are purchased or sold on a stock exchange, you may pay more or receive less than the current net asset value. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Why Taiwan Semiconductor Manufacturing, Micron, and ASML Holdings Fell Again Today
Shares of semiconductor leaders Taiwan Semiconductor Manufacturing (NYSE: TSM), Micron Technology (NASDAQ: MU), and ASML Holdings (NASDAQ: ASML) were all down again today, falling 4.2%, 4.1%, and 5.2%, respectively, as of 12:38 p.m. ET.
It was a terrible week for stocks generally and the artificial intelligence (AI) trade specifically, mostly due to macroeconomic concerns. Of note, the semiconductor industry has long been regarded as highly cyclical. While the sector has actually been the best-performing over the last decade due to its outsize long-term growth, the prospect of a slowdown or recession is causing investors to flee these industry leaders at the moment. This is especially true after artificial intelligence enthusiasm has lifted shares of these stocks by a large amount since November 2022 through July 2024.
It appears that a combination of today’s weaker-than-expected jobs report, along with AI tech peer Broadcom‘s mildly disappointing earnings report last night, are causing shares of all closely related AI-focused stocks to fall again today.
Weak jobs report fuels slowdown fears
This morning, the Labor Department reported the jobs figure for August. This was a big deal to many investors, as July’s much weaker-than-expected jobs report had fueled fears that the Federal Reserve was behind the curve in cutting interest rates.
While today’s jobs report showed an increase in August relative to July, and the unemployment rate fell slightly, it was still a bit below expectations. August saw 142,000 new job additions, up from the downwardly revised 89,000 added in July, but below the 161,000 that was expected. The unemployment rate ticked down to 4.2% from 4.3%.
It’s a bit hard to figure out why investors took this report that poorly, as it seems assured the Federal Reserve will cut interest rates at its meeting on Sept. 17 and 18. However, the “miss” as well as downward revisions of both the June and July job growth numbers fed uncertainty that the Federal Reserve is late in cutting rates, or won’t do enough cutting when its committee meets, which could potentially tip the economy into recession.
In any case, the market is in a very emotional mood this week, especially after the weak manufacturing data that came out to start the week on Tuesday morning.
Not helping matters was last night’s earnings report from Broadcom. While the chip and software giant beat analyst estimates for its fiscal third quarter, its semiconductor revenue may have disappointed, while management’s guidance for the fourth quarter also came in a bit lighter than analyst expectations.
As its name indicates, Broadcom’s portfolio spans many areas, including the iPhone, enterprise networking and storage, as well as custom artificial intelligence accelerators it makes for the in-house designs of several big tech giants.
Broadcom makes its chips largely at TSMC, likely using ASML’s EUV equipment, and Micron’s memory permeates all tech applications. So it’s not surprising all three reacted to Broadcom’s results.
Of note, Broadcom CEO Hock Tan said on the conference call with analysts that the AI business was very strong, with custom AI accelerators up 3.5 times year over year, Ethernet switching for AI data centers up 4 times year over year, and optical lasers up threefold. So, it’s hard to tell if the slightly weaker-than-expected forecast was conservative, if demand for AI products is decelerating faster than investors thought, or if Broadcom’s other non-AI products, whether iPhone chips, telco connectivity, or non-AI networking, continue to be weaker than anticipated. Of note, those non-AI products have already been in a big downturn, but are expected to recover.
Regardless, the overall lighter-than-expected chip revenue, even if AI remains strong, would affect TSMC, Micron, and ASML. While these companies are also benefiting handily from AI growth, each is also exposed to the entire broader semiconductor industry. ASML caught an unfortunate analyst downgrade on Wednesday, with the analyst pointing out that ASML’s AI exposure may not be as large as some have thought relative to the broader industry, perhaps adding to the downside in its shares.
This could be an opportunity
Semiconductor investors should know that the stocks within the sector are incredibly volatile, even if the sector has proven to be a long-term winner. So, benefiting from these names entails holding through big downturns such as these, or buying amid what seems like awful news in big downturns.
While the economy may be slowing, all three of these names are at the forefront of innovation and the AI growth opportunity. Despite the market’s reaction, the vast majority of tech executives this earnings season have said AI growth remains strong and should continue into next year, and likely beyond. With these stocks now well off their July highs, it may be time to think about adding to these leaders over the next rocky couple of months.
Should you invest $1,000 in Taiwan Semiconductor Manufacturing right now?
Before you buy stock in Taiwan Semiconductor Manufacturing, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Taiwan Semiconductor Manufacturing wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $656,938!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
*Stock Advisor returns as of September 3, 2024
Billy Duberstein and/or his clients have positions in ASML, Broadcom, Micron Technology, and Taiwan Semiconductor Manufacturing. The Motley Fool has positions in and recommends ASML and Taiwan Semiconductor Manufacturing. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy.
Why Taiwan Semiconductor Manufacturing, Micron, and ASML Holdings Fell Again Today was originally published by The Motley Fool
Bridging The Gap Between Financial Institutions And Cannabis Industry With Credit Scores
Credit scores might help add density to the somewhat depleted financial landscape of the cannabis industry, which has long struggled with access to traditional financial services as banks remain hesitant to offer loans, lines of credit or other support.
With the launch of CTrust’s Cannabis Trust Score (CTS), the industry is presented with a solution designed to help address these challenges and add to the cannabis financial market maturity. In this exclusive interview, we dive into the matter with CTrust’s founder Dotan Y. Melech.
The Need For Banking Solutions In Cannabis
Due to federal prohibition, financial institutions have found it difficult to serve cannabis-related businesses (CRBs), even in states where cannabis is legal. In this context, risk assessment tools might help banks and lenders evaluate the financial health of cannabis companies. At the same time, these instruments might be of assistance to financially healthy cannabis companies in need of gathering capital.
Melech emphasizes the magnitude of what we can call a transparency problem, that translates in reluctancy from financial institutions to build instruments for the cannabis industry.
“We have seen a serious gap between the needs of cannabis businesses and the willingness of financial institutions to engage with them,” Melech said. “This isn’t just a regulatory issue—it’s about financial security and growth. Cannabis businesses need access to the same services that other industries take for granted, such as loans and credit lines.”
The point being that adding instruments may help reduce the reluctance of lenders that have punished good cannabis business.
“Banks simply don’t have the tools to assess the risk associated with lending to cannabis companies. That’s where CTrust comes in,” Melech told Benzinga. “We’ve developed a proprietary algorithm that evaluates over 1,700 correlation points across 42 business categories. This isn’t a generic score; it’s specific to the cannabis industry, designed to give lenders the confidence they need to extend credit.”
Read Also: Are Banks Ready To Serve The Cannabis Industry? What One Expert Says About The Future
New To Industry Instruments
The Cannabis Trust Score offers also a detailed risk report, giving banks and other financial institutions clear insights into a cannabis companies’ financial stability.
“We evaluate three main areas: asset, structure, and character. These factors, combined with data from Metrc track-and-trace and point-of-sale systems, create a comprehensive picture of the company’s financial health,” Melech explains. “For the first time, lenders can base their decisions on solid data rather than fear or speculation.”
This risk assessment is critical in an industry where many financial institutions still operate under a cloud of uncertainty. According to Melech, “Cannabis businesses have always faced a cost of capital that’s far higher than what’s justified by their actual risk. With the CTS, we’re leveling the playing field. Financial institutions can now price loans fairly based on the individual business, not on the stigma of the industry.”
Read Also: What Investors Need To Know About 2024 Cannabis Risks In Under 3 Minutes
What Credit Scores Add To The Cannabis Industry
As the cannabis industry evolves, tools like the CTS will likely become more important. Many states, including California, have faced a wave of delinquent taxes and financial strain as cannabis companies struggle to stay afloat.
Melech sees the CTS as a critical step in addressing these issues: “When banks and investors can clearly understand the risk of lending to cannabis companies, they’re more willing to engage. This opens up lines of credit and makes it easier for cannabis businesses to grow and thrive.”
Looking to the future, he envisions a more inclusive financial system for cannabis companies.
“We believe that within the next five years, cannabis will be as bankable as any other industry. Banks just need the right tools to assess risk properly, and once they have those tools, capital will flow. The CTS is just the beginning—there’s a lot of potential here, not just for lending but for the entire financial ecosystem surrounding cannabis,” Melech said.
Get Benzinga’s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you’re serious about the business, you can’t afford to miss out.
Secondary Market For Cannabis Debts
By providing transparency and a data-driven approach to risk, CTrust is adding financial density to the industry. As more financial institutions adopt tools like credit scores tailored for the cannabis industry, cannabis businesses will find it easier to access the loans and credit they need to succeed, contributing to leaving the banking crisis in the rear mirror.
“Cannabis is no longer the wild west it was a decade ago… This industry is growing, maturing, and becoming more sophisticated by the day. It’s time for the financial world to catch up. With tools like the CTS, we believe we’re laying the foundation for a healthier, more accessible financial future for cannabis businesses everywhere.” Melech concluded. “There are a lot of great cannabis companies that have shown they are worthy of these financial services and fair pricing.”
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trump takes near-$4 billion hit on Truth Social since May — and the stock faces a fresh selling spree
-
The value of Donald Trump’s Truth Social stake has tanked by about $4 billion since May.
-
The ex-president may face further declines when stock-selling restrictions ease later this month.
-
Trump’s social-media platform has been hit by Kamala Harris’ momentum and his use of its rival X.
Donald Trump has seen about $4 billion wiped off the value of his Truth Social stake since May — and could suffer further losses once selling restrictions on the stock are lifted later this month.
The former president owns about 115 million shares of Trump Media & Technology Group, Truth Social’s parent company. It went public in March after merging with a special-purpose acquisition vehicle.
TMTG shares hit an intraday high of $79 on their market debut and traded at about $54 on May 9, but they’ve crashed 68% since then, hovering around a record low of about $17.
The heavy sell-off has cut the right-wing social-media company’s market value from about $10 billion in May to below $3.5 billion. It has slashed the value of Trump’s roughly 60% holding from about $6 billion to $2 billion over the same period.
The downturn reflects a shake-up in the presidential race, with Vice President Kamala Harris replacing President Joe Biden as the Democratic nominee. Harris is widely seen as a greater threat to Trump’s reelection chances — the pair are virtually tied in recent polls, while Trump held a steady lead over Biden.
And after a yearslong hiatus, Trump has resumed posting on Elon Musk’s X, which is perhaps the biggest rival to Truth Social. The ex-president’s use of his own social-media site instead of the platform formerly known as Twitter was seen as one of its biggest strengths — especially if he regained office.
Fast fall
Trump’s TMTG stake briefly catapulted him into the top 300 of the world’s 500 wealthiest people as measured by the Bloomberg Billionaires Index. The rich list estimated his net worth above $7 billion in late March, ranking him above the likes of George Soros, Mark Cuban, Giorgio Armani, Reed Hastings, and Bernie Marcus.
But the Republican presidential candidate quickly fell off the index once TMTG shares sank. Forbes pegs his current net worth below $4 billion — and Trump is not rich enough to still make the Bloomberg list.
Trump’s fortune could shrink further as the lock-up period on TMTG insiders selling shares expires later this month.
The real-estate mogul might cash out some of his shares, but Trump faces constraints on how fast he can sell and will have to make public regulatory filings when he reaches certain thresholds.
Read the original article on Business Insider
Zepp Health Corporation Announces Plan to Implement ADS Ratio Change
MILPITAS, Calif., Sept. 6, 2024 /PRNewswire/ — Zepp Health Corporation (“Zepp Health” or the “Company”) ZEPP, a global leader in smart wearables and health technology, today announced that it will change the ratio of its American depositary shares (“ADSs”) to its Class A ordinary shares (the “ADS Ratio”) from one (1) ADS representing four (4) Class A ordinary shares to one (1) ADS representing sixteen (16) Class A ordinary shares.
For the Company’s ADS holders, the change in the ADS Ratio will have the same effect as a one-for-four reverse ADS split. A post-effective amendment to the ADS Registration Statement on Form F-6 will be filed with the SEC to reflect the change in the ADS Ratio. The Company anticipates that the change in the ADS Ratio will be effective on or about September 16, 2024 (U.S. Eastern Time), subject to the effectiveness of the post-effective amendment to the ADS Registration Statement on Form F-6 on or before that date.
Each ADS holder of record at the close of business on the date when the change in ADS Ratio is effective will be required to surrender and exchange every four (4) existing ADSs then held for one (1) new ADS. Deutsche Bank Trust Company Americas, as the depositary bank for the Company’s ADS program, will arrange for the exchange of the current ADSs for the new ones.
No fractional new ADSs will be issued in connection with the change in the ADS Ratio. Instead, fractional entitlements to new ADSs will be aggregated and sold by the depositary bank and the net cash proceeds from the sale of the fractional ADS entitlements (after deduction of fees, taxes and expenses, where applicable) will be distributed to the applicable ADS holders by the depositary bank. The change in the ADS Ratio will have no impact on the Company’s underlying Class A ordinary shares, and no Class A ordinary shares will be issued or cancelled in connection with the change in the ADS Ratio. The Company’s ADSs will continue to be traded on the New York Stock Exchange under the ticker symbol “ZEPP.”
As a result of the change in ADS Ratio, the ADS trading price is expected to increase proportionately, although the Company can give no assurance that the ADS trading price after the change in the ADS Ratio will be equal to or greater than four times the ADS trading price before the change.
About Zepp Health Corporation
Zepp Health ZEPP, a global smart wearable and health technology leader, empowers users to live their healthiest lives through its leading consumer brands, including Amazfit, Zepp Clarity, and Zepp Aura. Leveraging its proprietary Zepp Digital Health Management Platform, Zepp Health delivers actionable insights and guidance to users worldwide. With a presence in over 90 countries and a robust ecosystem of products and services, Zepp Health is at the forefront of advancing wearable intelligence and digital health technology.
For more information on Zepp Health and its products, please visit www.zepp.com.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the cooperation with Xiaomi, the recognition of the Company’s self-branded products; the Company’s growth strategies; trends and competition in global wearable technology market; changes in the Company’s revenues and certain cost or expense accounting policies; governmental policies relating to the Company’s industry and general economic conditions in China and the global. Further information regarding these and other risks is included in the Company’s filings with the United States Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.
For investor and media inquiries, please contact:
Zepp Health Corporation
Grace Yujia Zhang
Email: ir@zepp.com
Piacente Financial Communications
Email: zepp@tpg-ir.com
View original content:https://www.prnewswire.com/news-releases/zepp-health-corporation-announces-plan-to-implement-ads-ratio-change-302240505.html
SOURCE Zepp Health Corp.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
'Roaring Kitty' Made Another Cryptic Post Today. Here's What Happened Next
Key Takeaways
-
“Roaring Kitty,” the figurehead of the meme stock craze, returned to posting on X on Friday, sending shares of GameStop and other meme stocks higher.
-
The characteristically cryptic post from Roaring Kitty may have led some to speculate he was going back to investing in GameStop.
-
The video game retailer reports earnings on Tuesday. Analysts see its revenue falling and loss widening.
“Roaring Kitty” is back, and meme stock investors are once again the beneficiaries.
Shares of video game retailer GameStop (GME) jumped after meme stock hero Roaring Kitty, whose real name is Keith Gill, posted on X for the first time since June. The shares later pared some of their gains, though they remained up about 6% late Friday afternoon.
Some may have read the post, an edited still from the movie “Toy Story 2,” as a message that Gill was dropping his investment in online pet retailer Chewy (CHWY), which he owned more than 6% of in early July, and switching back to GameStop. Chewy shares fell about 3% before recovering. Shares of AMC Entertainment Holdings (AMC), another meme favorite, were also rising late Friday.
GameStop Earnings on Deck
The buzz around GameStop comes just days before the company is set to release its second-quarter financial report. It’s expected to post a year-over-year drop in revenue and a wider net loss.
Wedbush analysts in a note Friday expressed skepticism about GameStop’s future. “The company continues to face a near insurmountable barrier to its planned return to growth,” they wrote, including the gaming industry’s shift toward digital sales and subscriptions, and the company’s “total lack of any strategy to enter new categories with growth potential.”
Wedbush reiterated its “underperform” rating of the stock, arguing that shares trade “at a level that ignores the company’s many challenges ahead.”
Nonetheless, shares of GameStop are up about 33% this year.
Read the original article on Investopedia.